Desferal, generically known as deferoxamine, is a medication primarily used in the treatment of acute iron poisoning and chronic iron overload due to transfusion-dependent anemias. It is an iron chelator, which means it binds to excess iron in the body, allowing it to be excreted through urine or feces, thereby reducing iron levels in the body. This is particularly important in conditions like thalassemia, where frequent blood transfusions can lead to an accumulation of iron, potentially causing damage to vital organs. Desferal is administered either through injection or infusion, depending on the severity of the iron overload and the specific needs of the patient. Its use is critical in preventing and managing the complications associated with iron overload, including liver disease, heart failure, and diabetes.